COM:ELIEMTX

Eliem Therapeutics

Stock

USD

Last Close

5.16

02/10 20:00

Market Cap

478.85M

Beta: -

Volume Today

802.69K

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-6.55M -	-20.67M 215.69%	-47.48M 129.73%	-45.24M 4.71%
depreciation and amortization			1.84M -
deferred income tax			-1.84M -	-1.39M 24.66%
stock based compensation		707K -	3.74M 428.57%	6.99M 87.08%
change in working capital	-309K -	-2.94M 850.16%	-4.17M 42.10%	210K 105.03%
accounts receivables
inventory
accounts payables	17K -	-24K 241.18%	150K 725%	-653K 535.33%
other working capital	-326K -	-2.91M 793.25%	-4.32M 48.42%	863K 119.97%
other non cash items	1.85M -	8.80M 376.14%	11.84M 34.59%	2.06M 82.57%
net cash provided by operating activities	-5.01M -	-14.10M 181.51%	-36.07M 155.87%	-37.37M 3.60%	-20.60M 44.88%
investments in property plant and equipment
acquisitions net
purchases of investments			-114.97M -	-87.96M 23.49%
sales maturities of investments				122.40M -
other investing activites		8.08M -			68.98M -
net cash used for investing activites		8.08M -	-114.97M 1,523.25%	34.44M 129.96%	68.98M 100.29%
debt repayment
common stock issued	26.24M -	4.92M 81.23%	83.14M 1,588.20%
common stock repurchased
dividends paid
other financing activites	26.24K -	4.92K 81.23%	94.09M 1,910,316.24%		841K -
net cash used provided by financing activities	26.24M -	4.92M 81.23%	177.23M 3,498.62%		841K -
effect of forex changes on cash	-12K -	359K 3,091.67%	245K 31.75%	-408K 266.53%
net change in cash	21.22M -	-736K 103.47%	26.43M 3,691.71%	-3.34M 112.62%	49.22M 1,575.07%
cash at beginning of period		21.22M -	20.49M 3.47%	46.92M 129.03%
cash at end of period	21.22M -	20.49M 3.47%	46.92M 129.03%	43.59M 7.11%	49.22M 12.94%
operating cash flow	-5.01M -	-14.10M 181.51%	-36.07M 155.87%	-37.37M 3.60%	-20.60M 44.88%
capital expenditure
free cash flow	-5.01M -	-14.10M 181.51%	-36.07M 155.87%	-37.37M 3.60%	-20.60M 44.88%

All numbers in USD (except ratios and percentages)